Altrinsic Global Advisors’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-70,000
Closed -$1.12M 67
2021
Q4
$1.12M Hold
70,000
0.04% 65
2021
Q3
$1.47M Hold
70,000
0.04% 68
2021
Q2
$1.88M Hold
70,000
0.06% 66
2021
Q1
$2.23M Hold
70,000
0.07% 63
2020
Q4
$1.6M Hold
70,000
0.05% 67
2020
Q3
$1.76M Sell
70,000
-10,000
-13% -$273K 0.07% 57
2020
Q2
$2.23M Sell
80,000
-10,000
-11% -$174K 0.1% 52
2020
Q1
$524K Buy
+90,000
New +$817K 0.03% 71

Other funds holding MGNX

Altrinsic Global Advisors's MGNX Position: Q1 2022 in Review

Altrinsic Global Advisors sold out of MacroGenics (MGNX) in Q1 2022, closing a stake of 70,000 shares — an estimated $1.12M sold.

Altrinsic Global Advisors first reported a position in MGNX in Q1 2020 and held it in 8 quarters. The position peaked at $2.23M in Q2 2020. 144 funds tracked by Wall St. Rank hold MGNX as of Q1 2022.

  • Altrinsic Global Advisors reported no remaining MacroGenics position as of Q1 2022 after selling out during the quarter.
  • Altrinsic Global Advisors sold 70,000 MacroGenics shares in Q1 2022, an estimated $1.12M.
  • Altrinsic Global Advisors first reported a position in MacroGenics in Q1 2020 and held it in 8 quarters.
  • Altrinsic Global Advisors's MacroGenics position peaked at $2.23M in Q2 2020.
  • 144 funds tracked by Wall St. Rank held MacroGenics as of Q1 2022.

Based on Altrinsic Global Advisors's 13F filing for Q1 2022, filed 16 May 2022.